Medpace Holdings (MEDP) Total Current Liabilities (2015 - 2026)
Medpace Holdings (MEDP) reported Total Current Liabilities of $1.3 billion for Q1 2026, up 19.84% on a YoY basis from $1.1 billion in Q1 2025, and little changed quarter-over-quarter from $1.3 billion in Q4 2025.
Medpace Holdings (MEDP) Total Current Liabilities (2015 - 2026) Analysis & Trends
Medpace Holdings has reported Total Current Liabilities for 12 years, with the latest figure at $1.3 billion in Q1 2026.
- For the quarter ending Q1 2026, Total Current Liabilities rose 19.84% year-over-year to $1.3 billion; the trailing twelve-month figure through Mar 2026 stood at $1.3 billion (up 19.84% YoY), and the FY2025 full-year result was $1.3 billion, up 21.66% from the prior year.
- Total Current Liabilities for Q1 2026 stood at $1.3 billion, roughly flat from $1.3 billion in the prior quarter.
- The five-year high for Total Current Liabilities was $1.3 billion in Q1 2026, with the low at $579.4 million in Q1 2022.
- Historically, Total Current Liabilities has averaged $1.0 billion across 5 years, with a median of $956.6 million in 2024.
- Annual changes were most pronounced in 2022 — Total Current Liabilities jumped 85.98% — and 2023, when it dropped 3.02%.
- Medpace Holdings' Total Current Liabilities stood at $803.5 million in 2022, then increased by 15.14% to $925.1 million in 2023, then gained by 19.39% to $1.1 billion in 2024, then gained by 21.66% to $1.3 billion in 2025, then grew by 0.09% to $1.3 billion in 2026.
- The last three Total Current Liabilities figures came in at $1.3 billion (Q1 2026), $1.3 billion (Q4 2025), and $1.3 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 29,902.70 Bn | 29,902.24 Bn | 1.11 Bn | 2.27 Bn |
| 2 | Thermo Fisher Scientific | 175.99 Bn | 172.74 Bn | 7.74 Bn | 14.62 Bn |
| 3 | Danaher | 129.87 Bn | 124.18 Bn | 3.59 Bn | 7.46 Bn |
| 4 | Idexx Laboratories | 44.75 Bn | 44.55 Bn | 722.74 Mn | 1.30 Bn |
| 5 | Agilent Technologies | 37.52 Bn | 35.72 Bn | 990.00 Mn | 2.27 Bn |
| 6 | Iqvia Holdings | 30.91 Bn | 28.94 Bn | 1.36 Bn | 8.33 Bn |
| 7 | Natera | 30.21 Bn | 29.11 Bn | 696.04 Mn | 558.26 Mn |
| 8 | Illumina | 24.19 Bn | 23.04 Bn | 721.00 Mn | 1.57 Bn |
| 9 | Mettler Toledo International | 23.12 Bn | 23.06 Bn | 555.82 Mn | 1.11 Bn |
| 10 | Medpace Holdings | 13.03 Bn | 12.38 Bn | 196.33 Mn | 1.35 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.35 Bn |
| Dec 31, 2025 | 1.34 Bn |
| Sep 30, 2025 | 1.28 Bn |
| Jun 30, 2025 | 1.22 Bn |
| Mar 31, 2025 | 1.12 Bn |
| Dec 31, 2024 | 1.10 Bn |
| Sep 30, 2024 | 1.04 Bn |
| Jun 30, 2024 | 993.09 Mn |
| Mar 31, 2024 | 956.65 Mn |
| Dec 31, 2023 | 925.13 Mn |
| Sep 30, 2023 | 848.52 Mn |
| Jun 30, 2023 | 852.44 Mn |
| Mar 31, 2023 | 881.89 Mn |
| Dec 31, 2022 | 803.47 Mn |
| Sep 30, 2022 | 820.87 Mn |
| Jun 30, 2022 | 878.96 Mn |
| Mar 31, 2022 | 579.43 Mn |
| Dec 31, 2021 | 557.22 Mn |
| Sep 30, 2021 | 517.18 Mn |
| Jun 30, 2021 | 472.61 Mn |